시장보고서
상품코드
2108187

소 뼈 유래 저분자 콜라겐 펩티드 시장 : 시장 분석 및 예측 - 유형별, 제품 유형별, 기술별, 용도별, 형태별, 제조 공정별, 최종 사용자별, 기능성별(-2035년)

Small Molecule Bovine Bone Collagen Peptides Market Analysis and Forecast to 2035: Type, Product, Technology, Application, Form, Process, End User, Functionality

발행일: | 리서치사: 구분자 Global Insight Services | 페이지 정보: 영문 350 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 4,750 금액 안내 화살표 ₩ 6,663,000
PDF & Excel (Site License) help
PDF, Excel 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다.
US $ 5,750 금액 안내 화살표 ₩ 8,066,000
PDF & Excel (Enterprise License) help
PDF, Excel 보고서를 동일 기업의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 6,750 금액 안내 화살표 ₩ 9,469,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 소 뼈 유래 저분자 콜라겐 펩티드 시장은 2025년 3억 8,000만 달러로 평가되었고, 2035년까지 8억 8,330만 달러로 성장이 전망되며, CAGR 8.8%로 확대될 것으로 예측됩니다. 소 뼈 유래 저분자 콜라겐 펩티드 시장은 식품, 뉴트라슈티컬, 의료 용도를 위한 콜라겐 유래 성분에 대한 규제 당국의 승인 및 과학적 연구 증가에 힘입어 성장하고 있습니다. 2025년, 유럽식품안전청(EFSA)은 콜라겐 유래 성분에 대한 신규 식품 신청 및 안전성 평가 심사를 지속했으며, 유럽연합(EU) 전역에서 영양 보충제 및 기능성 식품으로의 사용을 뒷받침했습니다. 생체 이용률이 향상된 가수분해 콜라겐 펩티드의 입수 가능성이 높아짐에 따라, 스포츠 영양, 건강한 노화, 피부 건강, 관절 건강 관련 제품에 대한 응용 범위가 확대되어 보다 광범위한 상용화에 기여하고 있습니다.

소 뼈 유래 저분자 콜라겐 펩티드의 유형별 부문에는 가수분해 콜라겐, 미변성 콜라겐, 기타가 포함됩니다. 가수분해 콜라겐은 저분자량, 높은 생체 이용률, 신속한 흡수라는 특징으로 인해 뉴트라슈티컬, 기능성 식품, 화장품 제제에 최적이며, 시장을 주도하는 부문으로 자리 잡고 있습니다. 관절, 뼈, 피부 건강에 대한 입증된 효능이 계속해서 광범위한 채택을 뒷받침하고 있습니다. 또한, 비변성 콜라겐도 천연 콜라겐 구조를 유지하며 연골 건강을 지원하는 능력 덕분에, 특히 관절 건강을 지원하는 보충제 분야에서 수요가 증가하고 있습니다.

소 뼈 유래 저분자 콜라겐 펩티드 시장의 ‘형태’ 부문에는 과립, 미세 분말, 기타가 포함됩니다. 미세 분말은 뛰어난 용해성, 혼합 용이성, 그리고 음료, 영양 보조제, 의약품 제제와의 호환성이 뛰어나 큰 시장 점유율을 차지하고 있습니다. 제조업체들은 입자 크기의 균일성, 안정성 향상, 대규모 생산 시의 편의성 때문에 미세 분말을 선호하여 사용하고 있습니다. 과립 또한 정제 제조나 소포장 영양보조식품에서 인기가 높아지고 있으며, 상업적 용도에서 유동성 향상, 취급 용이성 및 정확한 투여량 조절을 실현하고 있습니다.

지역별 개요

2025년, 아시아태평양은 기능성 건강 성분에 대한 수요 증가, 영양 보조제 소비 확대, 그리고 식품, 음료, 화장품, 헬스케어 제품에서의 콜라겐 펩티드 용도 확대에 힘입어 전 세계 소 뼈 유래 저분자 콜라겐 펩티드 시장에서 가장 큰 점유율을 차지했습니다. 중국, 일본, 한국, 인도 등의 국가들은 ‘내면에서 아름다움을 가꾸는’ 제품, 관절 건강을 지원하는 보충제, 단백질 기반 영양 솔루션에 대한 소비자 인식의 제고에 힘입어 시장의 주요 견인차 역할을 하고 있습니다. 이 지역은 고령 인구 증가, 가처분 소득 증가, 천연 및 생리활성 성분에 대한 강력한 수요라는 이점을 누리고 있습니다. 또한, 콜라겐 제조 기업의 존재, 전자상거래 유통 채널의 확대, 웰니스 및 예방 의료 제품에 대한 투자 증가가 시장 확장을 뒷받침하며, 전 세계 소 뼈 유래 저분자 콜라겐 펩티드 시장에서 아시아태평양의 주도적 위치를 강화하고 있습니다.

북미의 소 뼈 유래 저분자 콜라겐 펩티드 시장은 건강한 노화, 스포츠 영양, 미용 보충제, 기능성 식품에 대한 소비자의 관심 증가에 힘입어 예측 기간 동안 급속한 성장을 기록할 것으로 예측됩니다. 미국과 캐나다에서는 피부 건강, 뼈 강도, 관절 지원, 근육 회복과 관련된 이점에 대한 인식이 높아짐에 따라 콜라겐 펩티드를 기반으로 한 제품의 채택이 확대되고 있습니다. 이 지역은 확립된 기능성 식품 산업, 클린 라벨 원료에 대한 강력한 수요, 그리고 콜라겐 함유 제품의 혁신 발전과 같은 혜택을 누리고 있습니다. 또한, 영양 보충제, 의료용 영양 식품, 퍼스널케어 제품에서의 용도 확대에 더해, 첨단 콜라겐 가공 기술에 대한 투자 증가가 맞물려 시장 성장을 가속화하고 있으며, 북미를 가장 빠르게 성장하는 지역 시장으로 자리매김하고 있습니다.

주요 동향 및 촉진요인

미용·웰니스 분야에서의 가수분해 콜라겐 펩티드 활용 확대 :

소 뼈 유래 저분자 콜라겐 펩티드 시장에서는 미용, 영양, 웰니스 제품에 생체 이용률이 높은 콜라겐 원료가 채택되는 추세가 강해지고 있습니다. 소 뼈 유래 저분자 콜라겐 펩타드는 흡수성이 향상되었을 뿐만 아니라, 피부 탄력, 관절 건강, 뼈 강도, 그리고 전반적인 웰빙을 지원하는 능력이 있어 인기가 높아지고 있습니다. 각 제조업체들은 안티에이징 및 건강 지향 제품에 대한 소비자 수요 증가에 부응하기 위해, 이러한 펩티드를 영양 보조 식품, 기능성 음료 및 뉴트라슈티컬 제품의 배합에 점점 더 많이 도입하고 있습니다. 클린 라벨, 천연 유래이자 과학적으로 입증된 성분으로의 전환은 추가적인 혁신을 촉진하고, 소 콜라겐 펩티드의 용도 범위를 확대되고 있습니다.

콜라겐 기반 뉴트라슈티컬 및 건강한 노화 솔루션에 대한 수요 증가 :

건강한 노화, 관절 관리, 예방 의학에 대한 소비자의 관심이 높아지면서, 소 뼈 유래 저분자 콜라겐 펩티드 시장의 주요 성장 동력이 되고 있습니다. 피부 건강 개선, 결합 조직 지원, 골밀도 유지에 대한 콜라겐 보충의 이점에 대한 인식이 높아지면서, 고령층 및 건강 지향적인 소비자층 수요가 증가하고 있습니다. 또한, 영양 보조제 및 기능성 식품 산업의 확장은 콜라겐 펩티드 제조업체에게 보충제, 음료 및 맞춤형 영양 제품을 개발할 새로운 기회를 창출하고 있습니다. 웰니스 제품에 대한 투자 증가, 가처분 소득 상승, 그리고 천연 단백질 유래 성분에 대한 선호도 증가는 세계 시장의 성장을 더욱 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 하이라이트

제3장 시장 역학

제4장 부문 분석

제5장 지역별 분석

제6장 시장 전략

제7장 경쟁 정보

제8장 기업 개요

제9장 당사에 대해

AJY 26.08.18

The global Small Molecule Bovine Bone Collagen Peptides Market is projected to grow from $380.0 million in 2025 to $883.3 million by 2035, at a compound annual growth rate (CAGR) of 8.8%. The small molecule bovine bone collagen peptides market is supported by growing regulatory approvals and scientific research on collagen-based ingredients for food, nutraceutical, and medical applications. In 2025, the European Food Safety Authority (EFSA) continued evaluating novel food applications and safety assessments for collagen-derived ingredients, supporting their use in dietary supplements and functional foods across the European Union. The increasing availability of hydrolyzed collagen peptides with improved bioavailability has expanded their applications in sports nutrition, healthy aging, skin health, and joint health products, contributing to broader commercialization.

The Type segment of the Small Molecule Bovine Bone Collagen Peptides Market includes hydrolyzed collagen, undenatured collagen, and others. Hydrolyzed collagen represents the dominant market segment due to its low molecular weight, high bioavailability, and rapid absorption, making it ideal for nutraceuticals, functional foods, and cosmetic formulations. Its proven benefits for joint, bone, and skin health continue to support widespread adoption. Undenatured collagen is also witnessing growing demand, particularly in joint health supplements, owing to its ability to preserve the natural collagen structure and support cartilage health.

Market Segmentation
TypeHydrolyzed Collagen, Undenatured Collagen, Others
ProductPowder, Liquid, Capsules, Tablets, Others
TechnologySpray Drying, Freeze Drying, Others
ApplicationNutraceuticals, Cosmetics, Pharmaceuticals, Food & Beverages, Animal Feed, Others
FormGranules, Fine Powder, Others
ProcessEnzymatic Hydrolysis, Chemical Hydrolysis, Others
End UserHealthcare Providers, Pharmaceutical Companies, Cosmetic Manufacturers, Food & Beverage Industry, Others
FunctionalityBone Health, Joint Health, Skin Health, Weight Management, Others

The Form segment of the Small Molecule Bovine Bone Collagen Peptides Market includes granules, fine powder, and others. Fine powder holds a significant market share due to its excellent solubility, ease of blending, and compatibility with beverages, dietary supplements, and pharmaceutical formulations. Manufacturers prefer fine powder for its uniform particle size, improved stability, and convenience in large-scale production. Granules are also gaining popularity for tablet manufacturing and sachet-based nutraceutical products, offering improved flow properties, easier handling, and accurate dosing in commercial applications.

Geographical Overview

Asia Pacific held the largest share of the global Small Molecule Bovine Bone Collagen Peptides Market in 2025, driven by increasing demand for functional health ingredients, expanding nutraceutical consumption, and growing applications of collagen peptides in food, beverages, cosmetics, and healthcare products. Countries such as China, Japan, South Korea, and India are major contributors due to rising consumer awareness regarding beauty-from-within products, joint health supplements, and protein-based nutrition solutions. The region benefits from a large aging population, increasing disposable incomes, and strong demand for natural and bioactive ingredients. Additionally, the presence of collagen manufacturers, expanding e-commerce distribution channels, and growing investments in wellness and preventive healthcare products are supporting market expansion and strengthening Asia Pacifics leadership in the global small molecule bovine bone collagen peptides market.

The North America Small Molecule Bovine Bone Collagen Peptides Market is expected to register rapid growth during the forecast period, supported by rising consumer focus on healthy aging, sports nutrition, beauty supplements, and functional food products. The United States and Canada are witnessing increasing adoption of collagen peptide-based products due to growing awareness of benefits related to skin health, bone strength, joint support, and muscle recovery. The region benefits from a well-established nutraceutical industry, strong demand for clean-label ingredients, and increasing innovation in collagen-based formulations. Furthermore, expanding applications across dietary supplements, medical nutrition, and personal care products, combined with rising investments in advanced collagen processing technologies, are accelerating market growth and positioning North America as the fastest-growing regional market.

Key Trends and Drivers

Increasing Use of Hydrolyzed Collagen Peptides in Beauty and Wellness Applications:

The Small Molecule Bovine Bone Collagen Peptides Market is witnessing a growing trend toward the adoption of highly bioavailable collagen ingredients in beauty, nutrition, and wellness products. Small molecule collagen peptides derived from bovine bone are gaining popularity due to their improved absorption properties and ability to support skin elasticity, joint health, bone strength, and overall wellness. Manufacturers are increasingly incorporating these peptides into dietary supplements, functional beverages, and nutraceutical formulations to meet rising consumer demand for anti-aging and health-focused products. The shift toward clean-label, naturally derived, and scientifically supported ingredients is further encouraging innovation and expanding the application scope of bovine collagen peptides.

Rising Demand for Collagen-Based Nutraceuticals and Healthy Aging Solutions:

The increasing consumer focus on healthy aging, joint care, and preventive healthcare is a major driver of the Small Molecule Bovine Bone Collagen Peptides Market. Growing awareness regarding the benefits of collagen supplementation for improving skin health, supporting connective tissues, and maintaining bone density is boosting demand among aging populations and health-conscious consumers. Additionally, the expansion of the nutraceutical and functional food industries is creating new opportunities for collagen peptide manufacturers to develop supplements, beverages, and personalized nutrition products. Increasing investments in wellness products, rising disposable incomes, and growing preference for natural protein-based ingredients are further supporting market growth globally.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Application
  • 2.4 Key Market Highlights by Form
  • 2.5 Key Market Highlights by End User
  • 2.6 Key Market Highlights by Process
  • 2.7 Key Market Highlights by Technology
  • 2.8 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Hydrolyzed Collagen
    • 4.1.2 Undenatured Collagen
    • 4.1.3 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Powder
    • 4.2.2 Liquid
    • 4.2.3 Capsules
    • 4.2.4 Tablets
    • 4.2.5 Others
  • 4.3 Market Size & Forecast by Application (2020-2035)
    • 4.3.1 Nutraceuticals
    • 4.3.2 Cosmetics
    • 4.3.3 Pharmaceuticals
    • 4.3.4 Food & Beverages
    • 4.3.5 Animal Feed
    • 4.3.6 Others
  • 4.4 Market Size & Forecast by Form (2020-2035)
    • 4.4.1 Granules
    • 4.4.2 Fine Powder
    • 4.4.3 Others
  • 4.5 Market Size & Forecast by End User (2020-2035)
    • 4.5.1 Healthcare Providers
    • 4.5.2 Pharmaceutical Companies
    • 4.5.3 Cosmetic Manufacturers
    • 4.5.4 Food & Beverage Industry
    • 4.5.5 Others
  • 4.6 Market Size & Forecast by Process (2020-2035)
    • 4.6.1 Enzymatic Hydrolysis
    • 4.6.2 Chemical Hydrolysis
    • 4.6.3 Others
  • 4.7 Market Size & Forecast by Technology (2020-2035)
    • 4.7.1 Spray Drying
    • 4.7.2 Freeze Drying
    • 4.7.3 Others
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Bone Health
    • 4.8.2 Joint Health
    • 4.8.3 Skin Health
    • 4.8.4 Weight Management
    • 4.8.5 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Application
      • 5.2.1.4 Form
      • 5.2.1.5 End User
      • 5.2.1.6 Process
      • 5.2.1.7 Technology
      • 5.2.1.8 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Application
      • 5.2.2.4 Form
      • 5.2.2.5 End User
      • 5.2.2.6 Process
      • 5.2.2.7 Technology
      • 5.2.2.8 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Application
      • 5.2.3.4 Form
      • 5.2.3.5 End User
      • 5.2.3.6 Process
      • 5.2.3.7 Technology
      • 5.2.3.8 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Application
      • 5.3.1.4 Form
      • 5.3.1.5 End User
      • 5.3.1.6 Process
      • 5.3.1.7 Technology
      • 5.3.1.8 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Application
      • 5.3.2.4 Form
      • 5.3.2.5 End User
      • 5.3.2.6 Process
      • 5.3.2.7 Technology
      • 5.3.2.8 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Application
      • 5.3.3.4 Form
      • 5.3.3.5 End User
      • 5.3.3.6 Process
      • 5.3.3.7 Technology
      • 5.3.3.8 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Application
      • 5.4.1.4 Form
      • 5.4.1.5 End User
      • 5.4.1.6 Process
      • 5.4.1.7 Technology
      • 5.4.1.8 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Application
      • 5.4.2.4 Form
      • 5.4.2.5 End User
      • 5.4.2.6 Process
      • 5.4.2.7 Technology
      • 5.4.2.8 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Application
      • 5.4.3.4 Form
      • 5.4.3.5 End User
      • 5.4.3.6 Process
      • 5.4.3.7 Technology
      • 5.4.3.8 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Application
      • 5.4.4.4 Form
      • 5.4.4.5 End User
      • 5.4.4.6 Process
      • 5.4.4.7 Technology
      • 5.4.4.8 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Application
      • 5.4.5.4 Form
      • 5.4.5.5 End User
      • 5.4.5.6 Process
      • 5.4.5.7 Technology
      • 5.4.5.8 Functionality
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Application
      • 5.4.6.4 Form
      • 5.4.6.5 End User
      • 5.4.6.6 Process
      • 5.4.6.7 Technology
      • 5.4.6.8 Functionality
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Application
      • 5.4.7.4 Form
      • 5.4.7.5 End User
      • 5.4.7.6 Process
      • 5.4.7.7 Technology
      • 5.4.7.8 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Application
      • 5.5.1.4 Form
      • 5.5.1.5 End User
      • 5.5.1.6 Process
      • 5.5.1.7 Technology
      • 5.5.1.8 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Application
      • 5.5.2.4 Form
      • 5.5.2.5 End User
      • 5.5.2.6 Process
      • 5.5.2.7 Technology
      • 5.5.2.8 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Application
      • 5.5.3.4 Form
      • 5.5.3.5 End User
      • 5.5.3.6 Process
      • 5.5.3.7 Technology
      • 5.5.3.8 Functionality
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Application
      • 5.5.4.4 Form
      • 5.5.4.5 End User
      • 5.5.4.6 Process
      • 5.5.4.7 Technology
      • 5.5.4.8 Functionality
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Application
      • 5.5.5.4 Form
      • 5.5.5.5 End User
      • 5.5.5.6 Process
      • 5.5.5.7 Technology
      • 5.5.5.8 Functionality
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Application
      • 5.5.6.4 Form
      • 5.5.6.5 End User
      • 5.5.6.6 Process
      • 5.5.6.7 Technology
      • 5.5.6.8 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Application
      • 5.6.1.4 Form
      • 5.6.1.5 End User
      • 5.6.1.6 Process
      • 5.6.1.7 Technology
      • 5.6.1.8 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Application
      • 5.6.2.4 Form
      • 5.6.2.5 End User
      • 5.6.2.6 Process
      • 5.6.2.7 Technology
      • 5.6.2.8 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Application
      • 5.6.3.4 Form
      • 5.6.3.5 End User
      • 5.6.3.6 Process
      • 5.6.3.7 Technology
      • 5.6.3.8 Functionality
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Application
      • 5.6.4.4 Form
      • 5.6.4.5 End User
      • 5.6.4.6 Process
      • 5.6.4.7 Technology
      • 5.6.4.8 Functionality
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Application
      • 5.6.5.4 Form
      • 5.6.5.5 End User
      • 5.6.5.6 Process
      • 5.6.5.7 Technology
      • 5.6.5.8 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Rousselot
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Gelita
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Nitta Gelatin
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 PB Leiner
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Weishardt
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Gelnex
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Lapi Gelatine
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Ewald Gelatine
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Trobas Gelatine
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Norland Products
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Great Lakes Gelatin
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Vital Proteins
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Collagen Solutions
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Amicogen
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 BioCell Technology
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Darling Ingredients
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Titan Biotech
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Holista Colltech
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Nutra Food Ingredients
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Junca Gelatines
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기